Integrated Filing — IndAS



General information about company
Scrip Code 543389
NSE Symbol SIGACHI
MSEI Symbol NOTLISTED
ISIN INE0D0K01022
Name of company SIGACHI INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 25-Jul-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Phamaceucticals
Start date and time of board meeting 25-Jul-2025   12:00:00
End date and time of board meeting 25-Jul-2025   15:55:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1282462000
Other income 39432000
Total income 1321894000
2 Expenses
(a) Cost of materials consumed 616150000
(b) Purchases of stock-in-trade 27319000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -15504000
(d) Employee benefit expense 195553000
(e) Finance costs 33065000
(f) Depreciation, depletion and amortisation expense 47246000
(f) Other Expenses
1 Manufacturing Expenses 107705000 107705000
2 Rent 6302000 6302000
3 Insurance 9644000 9644000
4 Selling Expenses 12711000 12711000
5 Travelling and Conveyance 14904000 14904000
6 Professional and Consultancy fees 14853000 14853000
7 Carriage Outward 29017000 29017000
8 CSR 2596000 2596000
9 Communication Expenses 3205000 3205000
10 Other Expenses 16993000 16993000
Total other expenses 217930000
Total expenses 1121759000
3 Total profit before exceptional items and tax 200135000
4 Exceptional items -1210064000
5 Total profit before tax -1009929000
6 Tax expense
7 Current tax 1063000
8 Deferred tax -1284000
9 Total tax expenses -221000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations -1009708000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period -1009708000
17 Other comprehensive income net of taxes -145000
18 Total Comprehensive Income for the period -1009853000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent -1003547000
Total profit or loss, attributable to non-controlling interests -6162000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent -1003452000
Total comprehensive income for the period attributable to owners of parent non-controlling interests -6401000
21 Details of equity share capital
Paid-up equity share capital 382117000
Face value of equity share capital 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -2.63
Diluted earnings (loss) per share from continuing operations -2.63
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -2.63
Diluted earnings (loss) per share from continuing and discontinued operations -2.63
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Theaboveunauditedstandalonefinancialresultsforthequarterended30062025havebeenreviewedbytheAuditCommitteeandapprovedbytheBoardofDirectorsoftheCompanyattheirrespectivemeetingsheldon25072025ThestandalonefinancialresultsoftheCompanyhavebeenpreparedinaccordancewiththeIndianAccountingStandardsasprescribedundersection133oftheCompaniesAct2013readwithCompaniesIndianAccountingStandardsRules2015asamendedandintermsofregulation33oftheSEBIListingObligationsandDisclosureRequirements2015asammendedThere was afireaccidentoccurredinthepremisesofHyderabadplantlocatedatPashamylaramTelangana.Unfortunatelythisaccidentcausedalossof46teammembers8unaccountedteammembersand28teammemberswereinjuredoutof25memberswererecoveredanddischargedThefirealsocauseddamagestoourPropertyPlantandEquipmentandinventoriesThe operationsattheplantweretemporarilypausedforanestimatedperiodof180daystofacilitatereplacementandrestorationofeffectedequipmentandstructuresThelossesarisingonaccountofthefireaccidenttowardslossofPropertyPlantandEquipmentinventoriesandthecompensationtotheeligiblebeneficiariesmedicalexpenseshavebeenaccountedunder exceptionalitemThecompanyhassubmittedtheinitialinsuranceclaimsandpendingsubmissionofthefinalinsuranceclaimsnoincomefrominsuranceclaimshasbeenaccountedforinthesefinancialresults nTheCompanyhasasinglereportingsegmentthatofPharmaceuticals



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss 1320000 1320000
2 Income tax relating to items that will not be reclassified to profit or loss -461000 -461000
Total Amount of items that will not be reclassified to profit and loss 859000
2 Income tax relating to items that will not be reclassified to profit or loss 0
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit and loss -1004000 -1004000
Total Amount of items that will be reclassified to profit and loss -1004000
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income -145000